Fast protein liquid chromatography (FPLC) for protein purification
Fast protein liquid chromatography (FPLC) is a widely used technique for the purification of proteins and biomolecules under controlled conditions.
Unlike high-performance liquid chromatography (HPLC), FPLC operates at lower pressures, making it particularly suitable for proteins, enzymes, and other large biomolecules that require mild purification conditions. It has been an essential tool in biochemical, pharmaceutical, and molecular biology research, where high-resolution protein purification is crucial.
Purifying proteins is essential for a range of applications, including drug development, enzymatic studies, structural biology, and biomarker discovery. FPLC offers a high degree of reproducibility, automation, and scalability, making it a preferred choice over traditional purification methods such as dialysis, precipitation, and ultracentrifugation. By preserving the structural integrity of proteins, FPLC ensures that functional assays, crystallization, and therapeutic applications can proceed with high-quality samples.
The need for high-purity proteins has driven innovation in chromatography techniques. FPLC is particularly useful for proteins that require minimal exposure to harsh chemicals and physical forces. The continued evolution of FPLC technology, including automation and real-time monitoring, has made it an indispensable tool in both academic and industrial settings. Advances in resin technology, column efficiency, and software integration have further expanded its applications in biotechnology and pharmaceutical development.
Principles and purpose of fast protein liquid chromatography
The basic principle underlying FPLC is a medium-pressure chromatography method that purifies proteins and other large biomolecules by facilitating their interaction between a liquid mobile phase and a cross-linked agarose resin within a column. It uses the constant flow of aqueous buffers, with a programmed gradient of elution buffers controlled via a computer.
The elution can use the increasing ionic strength of a salt solution to dissociate bound proteins; weaker-bound peptides elute first, and stronger-bound peptides elute later. The eluant is passed through an ultra-violet (UV) light detector that measures the concentration of salt by conductivity and the concentration of protein via UV absorption.
Separation mechanism of fast protein liquid chromatography
Unique features of fast protein liquid chromatography
-
Biocompatible materials and low-pressure operation of FPLC, compared with the high-pressure conditions of HPLC, make it ideal for preserving proteins, large biomolecules (especially biopolymers), and peptides that may be several kilodaltons (kDa) in size during the time of purification.
-
FPLC is used in cold environments to preserve the integrity of the protein being purified.
-
Common FPLC processes include gel filtration, ion exchange, reverse phase, and affinity. The resins used in the stationary phase vary depending on the chromatographic process involved:
- IEC: DEAE, quaternary amino anion (Q), CM, Sulfonic acid (S).
- SEC: Agarose, dextran, polyacrylamide.
- Affinity chromatography: Protein A, Protein G, Ni-NTA, specific ligand-functionalized resins.
- HIC: Phenyl, butyl, octyl ligand-coated resins.
- RPC: Hydrophobic silica, polymer-based resins.
-
FPLC’s versatility and cost-effectiveness improve its efficiency and provide significant advantages—this helps in providing economically viable protein biomolecules which include enzymes and hormones.
Key components and setup of an FPLC system
A typical FPLC setup comprises several key components, each serving a distinct function to ensure precise and efficient separation.
Pumps and flow control
FPLC systems use precise, low-to-medium pressure pumps to maintain consistent flow rates and pressure. This enables accurate nano-flow solvent delivery and gradient elution for high-resolution separations. These pumps, including dual-piston reciprocating, syringe-type designs, and peristaltic pumps, ensure efficiency and reliability in complex separations.
Injection systems and sample loading
Injection systems consist of two main parts:
- Injection loop: A segment where a known volume of the sample is loaded before the actual injection.
- Injection valve: This connects the mixer and the injection loop and includes a sample loading section, an injecting section, and a wash-line connector section for cleaning.
The FPLC injection system ensures precise sample loading with minimal carry-over, such as through a stop-flow injector that handles volumes as low as 10 nanoliters. This ensures reproducibility in protein purification and biomolecular separations.
Columns and stationary phases
FPLC columns are made of glass or plastic. The choice of stationary phase helps in optimizing chromatographic performance and selectivity. Among the many resins discussed earlier, the use of immobilized metal affinity chromatography with the Ni2+-NTA resin, with Ni2+ bound to a solid support immobilized with NTA by chelation to bind biomolecules carrying either a C- or N-terminal histidine (His) tag, is common.
Detectors
FPLC systems use detectors such as UV absorption monitors (measuring at 280 nm), conductivity meters, and pH meters to track the separation process in real time. The UV-absorption detector offers high sensitivity when operated at a wavelength as close as possible to the absorption maximum.
Other recommendations include a spectral bandwidth that is as narrow as possible, and the frequency of the detector signal storage suggested to be between 10 and 20 data points per chromatographic peak. The advantages include ease of use, minimal sample preparation (only dilution), recovery of precious samples for further assays, and linearity. In addition to aiding in fraction collection and composition analysis, the UV detector can also be used in the quality control of chromophoric compounds, such as pharmaceuticals.
Fraction collectors
Fraction collectors in FPLC systems automatically collect eluted fractions based on predefined criteria according to the requirements of research. They are based on specific fractions at protein peak concentrations or fixed volumes or aliquots, working with detectors to ensure efficient and accurate purification. This automation enhances the overall process by reducing manual intervention and increasing throughput.
Types of fast protein liquid chromatography techniques and columns
The basic principles underlying FPLC techniques include:
- Stationary and mobile phases: Biomolecules interact with a resin-based stationary phase while being transported by an aqueous mobile phase.
- Binding and elution: Proteins bind based on charge, size, affinity, and hydrophobicity and are eluted by modifying buffer conditions (pH, salt, and solvents).
- Gradient elution: Gradual changes in buffer composition enhance separation precision and resolution.
- Real-time monitoring: UV, conductivity, and pH detectors track purification efficiency and protein elution.
Ion-exchange chromatography
IEC purifies proteins and monoclonal antibodies by separating molecules with minor charge differences through the reversible exchange of ions between a resin and the solution. The stationary phase, typically cellulose-based, binds molecules with opposite charges. Cation-exchange resins (negatively charged) bind positively charged molecules, whereas anion-exchange resins (positively charged) bind negatively charged molecules.
Functional groups in cation exchange beads include CM, methyl sulfonate (S), and sulfopropyl (SP), while anion exchangers use quaternary aminoethyl (QAE), DEAE, and Q. To ensure effective separation, the protein’s isoelectric point (pI) should be known. For anion exchange, the buffer pH should be 1 unit above the protein’s pI, whereas for cation exchange, it should be 1 unit below. The buffer should not bind the column beads and should help maintain protein stability.
For FPLC, binding buffers have low or no salt, and elution buffers have high salt. Primary antibodies are typically purified using anion exchange on DEAE resins. FPLC ion-exchange columns can also separate DNA fragments up to 500–600 bp, with customizable settings such as pH and flow rate. Anion-exchange FPLC has been shown to produce RNA and enrich tRNA (Cys) in aminoacylation assays.
Factors that influence the column of the FPLC for IEC are:
- Charge (cation or anion)
- pH range
- Ionic strength of the target molecules
Size-exclusion chromatography
SEC separates molecules based on size as they pass through a porous stationary phase, such as agarose beads. Larger molecules, unable to enter the pores, elute first, while smaller molecules, which diffuse in and out of pores, elute later. The larger molecules elute first because the smaller molecules have greater retention. This is known as steric exclusion.
Secondary exclusion further enhances efficiency, as smaller molecules diffuse more within the matrix, while larger molecules are confined to the interstitial spaces, leading to faster elution.
Recombinant proteins, such as deleted in malignant brain tumor 1 (DMBT1), are purified using an optimized SEC-FPLC protocol, achieving high purity and enhanced bacterial agglutination activity.
Factors affecting the FPLC column for SEC are:
- Pore size
- Length of column
- Size of the molecule to be separated
Affinity chromatography
Affinity chromatography isolates biomolecules based on their specific interactions with a ligand attached to the chromatography matrix. This method relies on reversible binding, commonly seen in biological reactions such as enzyme-substrate, antibody-antigen, and receptor-hormone interactions. The ligand is immobilized on a support material, which serves as the stationary phase, selectively binding the target molecule when the sample mixture is applied to the column.
The sample is initially passed in an application buffer to allow target-ligand binding. The target is then eluted using a mobile phase (elution buffer) that can alter ionic strength or pH, or using a competitive binding agent that displaces the target molecule.
Common support materials include agarose, cellulose, glass, silica, polystyrene, and titania. In immunoaffinity chromatography, the binding of antibodies to the target is harnessed for separation. Examples of such ligands include protein A from Staphylococcus aureus, protein G, and protein L derived from Peptostreptococcus magnus. These ligands bind to immunoglobulins such as IgG and IgA for purification.
Affinity purification has been simplified with affinity tags such as glutathione-S-transferase and hexa-histidine. The hexa-histidine tag is effective under denaturing conditions such as urea presence. Abcam provides antibodies for screening, such as biotin anti-6× His tag® antibody and HRP anti-6× His tag.
FPLC with functionalized media can separate modified proteins from unmodified ones, aiding in protein modification studies. It has been used to purify the therapeutic antibody trastuzumab expressed in HEK-293 cells. Another study detailed optimizing conditions for 6×-His-tagged flap endonuclease 1 (FEN1), including column preparation, packing, sample injection, flow rate, and elution. Factors such as ligand affinity, interaction specificity, and selectivity influence FPLC column performance.
Hydrophobic interaction chromatography
HIC separates biomolecules based on their hydrophobicity, using a matrix that interacts with nonpolar regions. In FPLC, HIC quantifies biomolecules across fractions, offering insights into their distribution, function, and biological origin in complex samples.
HIC is used to quantify sphingolipids, enabling the characterization of sphingolipid species profiles in human plasma lipoprotein fractions. Because these lipids are linked to vascular diseases and cancer, HIC helps identify distinct sphingolipid patterns, enhancing the understanding of their physiological and pathological roles.
Reverse-phase chromatography
In RPC, the stationary phase is typically nonpolar, such as silica or polymer beads. This technique separates molecules based on hydrophobic interactions. It is commonly used for peptides, small proteins (<100 kDa), amino acids, oligonucleotides, and organic molecules.
A gradient elution approach involves using hydrophilic (water-based) and hydrophobic (water-repelling) mobile phases. Hydrophilic molecules thus elute first, whereas more hydrophobic molecules elute later. The target molecules have a stronger affinity for the hydrophobic stationary phase, and are eluted when their affinity for the hydrophobic eluant exceeds that for the stationary phase.
The aqueous mobile phase usually contains water, acid additives, and buffers such as phosphate-buffered saline. Organic solvents such as acetonitrile, methanol, or mixtures of acetonitrile with isopropanol or n-butanol are used for specific applications such as those involving monoclonal antibodies.
When selecting an FPLC column for RPC, factors such as stationary phase, pore size, column length, and analyte polarity must be considered for optimal resolution. The pH of the mobile phase and the ratio of hydrophilic to hydrophobic solvent, along with the flow rate, also affect retention and separation efficiency.
Steps involved in the FPLC process for protein purification
FPLC involves steps such as sample loading, separation, detection, and fraction collection.
Preparing the system and sample
System and sample preparation in FPLC involves:
- Cleaning and calibrating the system to remove contaminants and avoid interference in detection
- Enriching target analytes to measurable concentrations
- Ensuring compatibility with the chromatographic system using techniques such as liquid extraction, solid-phase extraction, and filtration.
- Making specific adjustments, such as reducing ionic strength after precipitation, to ensure optimal protein purification.
Setting and running gradients for effective separation
Setting and running gradients for effective protein separation is required to differentiate proteins based on charge, size, or affinity. The process involves:
- Selecting suitable running buffers
- Designing a gradient program
Particularly, buffers should not interfere with the activity of the target protein. The concentration and the pH of the buffer used should be in line with the target protein. To maintain protein stability and mimic physiological conditions, salts are added to the buffer.
Care must be taken to ensure that the salt requirements may vary as per the chromatographic approach, column, and elution gradients. For example, salt levels affect protein L affinity columns more than they do protein A resins. The elution is facilitated at a higher pH when the salt concentration is lowered in the mobile phase in protein L columns. The purification of targets (such as antibodies) can become more stringent when increasing the pH by reducing salt concentrations to remove weakly bound molecules.
Mixed pH and salt gradients or automated buffer preparation with quaternary valves can optimize elution conditions and streamline complex steps.
Peak detection, analysis, and fraction collection
After completing the gradient run, protein peaks are detected and analyzed using in-line monitors, such as UV, conductivity, and pH meters. Fractions are then collected for further analysis. This approach is used in high-resolution separations of tagged proteins and tandem purification of monoclonal antibodies.
UV detectors called variable wavelength detectors (VWDs or UV-visible absorbance detectors) are modified spectrophotometers with a fuel cell instead of a cuvette. These detectors facilitate the identification of functional groups, geometry, and purity based on the emission spectra of a target irradiated with light. The diode array detector (DAD) or photodiode array (PDA) provides the UV spectra of peaks that elute in chromatographic separation and, when combined with software analyses, can allow library searches of UV spectra and peak purity analysis where an impurity has a different spectral pattern.
A few examples of next-generation UV detectors include the ongoing development of semiconductor nanostructures with enhanced detection, such as a niobium pentoxide (Nb2O5) nanobelt UVA detector, cadmium sulfide (CdS) and zinc oxide (ZnO) nanowells on a diamond substrate, and gallium nitride (GaN) UV detectors with annealed silver nanoparticles, which show higher sensitivity than do only GaN detectors. Another development is the use of optical fiber to augment the UV-detection response speed. For instance, a fiber-optic UV photodetector based on a ZnO micro-pillar and silver film showed fast responses (rise time was 35 ns and decay time was 40 µs) for potential application in photodetectors.
Continuous monitoring during linked purification steps further enhances accuracy and efficiency. Interesting developments include combining IEC with UV detectors to separate pharmaceutical drugs such as ibuprofen and valproic acid by using gradient/isocratic elutions that show few discrepancies. This approach is also used in high-resolution separations of tagged proteins and tandem purification of monoclonal antibodies.
System cleaning, maintenance, and regeneration post-run
Post-run system cleaning, maintenance, and regeneration in FPLC involve:
- Flushing with cleaning solutions, such as 1 M sodium hydroxide (NaOH) and distilled water or 0.5 M NaOH, and with 2.0 M NaCl (wash buffer) for Ni-NTA FPLC columns to remove contaminants
- Regenerating or replacing used columns, such as immobilized metal affinity chromatography resin. The use of a strip buffer (100 mM EDTA, pH 8.0) and a wash buffer (10 mM NiSO₄) is recommended for regenerating Ni-NTA FPLC columns.
Regular maintenance and calibration are essential to ensure consistent performance and extend the system’s longevity.
Interpreting and analyzing fast protein liquid chromatography data
Interpreting and analyzing FPLC data involves examining chromatograms to identify protein peaks, determine elution profiles, and assess protein purity and concentration. Chromatogram interpretation involves peak detection, baseline correction, and integration with advanced algorithms and statistical methods for improving accuracy and automation.
Techniques such as independent component analysis (ICA) help differentiate noise from true peaks, while automated data processing minimizes human intervention and optimizes batch review. Accurate peak quantification in FPLC is essential for determining analyte concentration and relies on retention time, peak area, and shape, ensuring precise boundary setting and reliable analysis.
Software and tools available for FPLC data analysis
Various software tools help enhance data analysis by improving peak detection, alignment, and interpretation, utilizing advanced features such as retention time alignment, log-normal peak fitting, and deep learning for complex datasets.
Applications of fast protein liquid chromatography in biotechnology and research
FPLC has significant applications in purifying proteins and isolating nucleic acid biomolecules. It offers a rapid and efficient method for RNA purification, overcoming the limitations of traditional PAGE-based techniques, such as lengthy protocols, RNA aggregation, and contamination with acrylamide oligomers.
Using FPLC SEC columns enables the isolation of milligram quantities of pure homogeneous RNA in less than a day, providing high-resolution RNA samples suitable for structural studies.
Examples of FPLC in pharmaceutical development
FPLC in pharmaceutical development is used in the purification and analysis of monoclonal antibodies, enzyme inhibitors, recombinant antibodies, and therapeutic peptides, all of which are crucial in the production of protein-based drugs.
FPLC plays a critical role in ensuring consistency, purity, and activity of proteins used in therapeutic applications, helping to meet regulatory standards, eg, FPLC is used to develop an optimized method for purifying non-denatured protein from the uropathogenic Escherichia coli, enabling more accurate host-pathogen interaction studies and immune assays.
Advantages and limitations of fast protein liquid chromatography
Understanding the advantages and limitations of FPLC helps in determining its suitability for specific biomolecular purification and analysis needs.
The low pressure used in FPLC reduces the probability of protein degradation, allowing the separation and purification of proteins in their native states. The advantage of small volumes needed in FPLC analysis was used for the proteomic analysis of blood lipoproteins. In the analysis, the limit of detection of soymilk adulteration in bovine milk using FPLC was 1% vs. 5% for SDS-PAGE (which also had challenges in interpreting the results and the time taken), showing the potential of FPLC.
Advantages
- Automation capabilities: FPLC systems are highly automated, incorporating multiple pumps, in-line UV absorption monitors, conductivity meters, pH meters, and fraction collectors, which enhance the efficiency of the purification process.
- Scalability: FPLC systems are available in various scales, from analytical research settings to large-scale industrial purification processes. The technique is easily scalable for pharmaceutical applications, including the purification of monoclonal antibodies and viral vectors.
- Integration with downstream processing: FPLC can be integrated well into downstream bioprocessing steps, such as ultrafiltration and lyophilization, facilitating the transition from protein purification to formulation in drug development.
Limitations
- Pressure limitations: FPLC systems function at lower pressures than other high-performance liquid chromatography (HPLC) systems, potentially limiting the speed of separations.
- Not sensitive to thermolabile proteins: FPLC may not be ideal for proteins sensitive to temperature variations, as its operational conditions may not be suitable for such proteins.
- Sample complexity: FPLC may face challenges with highly complex samples, particularly those with a high concentration of specific proteins, which can exceed the system's resolution capacity.
Why choose FPLC over other chromatography techniques?
FPLC can be chosen over other chromatography techniques because it has been developed to include automation, giving better control, small-diameter stationary phases to allow high-resolution separation, high flow rates, and biocompatible aqueous buffers, ensuring consistent and reproducible results. These features make FPLC a dependable solution for diverse applications.
FPLC is preferred for protein and RNA purification, as it preserves the biological activity and structure of delicate biomolecules. It is also effective in separating isoenzymes, making it valuable for biochemical and clinical research.
Recent advances and future perspectives in fast protein liquid chromatography
Recent advancements in FPLC, including miniaturization and automation of gradient control, autosampling, and peak collection, have enhanced efficiency and scalability in protein purification. These innovations enable improved parallel processing, reduced material consumption, and the integration of real-time data analysis, leading to faster and more reproducible results.
Autosampling integrates pumps and switching valves with FPLC along with software to allow automated running.
Emerging applications in biotechnology and pharmaceuticals
FPLC is increasingly used in emerging biotechnology and pharmaceutical applications for purifying therapeutic proteins and other biomolecules, with its automated techniques revolutionizing high-throughput screening and simplifying processes in molecular diagnostics and biotherapeutic development.
For instance, 6x his-tagged cytoskeletal proteins can be isolated using FPLC, which is important owing to the critical roles these proteins play in cell division and organelle transport, both in health and disease.
FPLC was used in another study to characterize bacteriophage Qβ-based virus-like particles (VLPs), which showed surface proteins such as proprotein convertase subtilisin/kexin-9 (PCSK9), apolipoprotein B (ApoB), and cholesteryl ester transfer protein (CETP), for developing a trivalent vaccine candidate that targeted these cholesterol checkpoint proteins as an alternative to statins.
FAQs
What are the main applications of FPLC in biochemistry and enzymology?
Fast protein liquid chromatography (FPLC) is mainly used in biochemistry and enzymology for the purification and separation of proteins, enzymes, and other biomolecules, such as RNA, lipoproteins, etc., based on size, charge, hydrophobicity, or affinity. It is essential for isolating specific proteins for structural studies, enzyme activity assays, and drug development.
How does FPLC differ from HPLC in terms of column materials and pressure tolerance?
FPLC uses columns made of materials such as glass or plastic that operate at low to medium pressures to accommodate the sensitivity of biomolecules to facilitate the purification of large biomolecules, such as proteins. HPLC utilizes metal columns designed for high pressures for analyzing small molecules and less fragile compounds for detailed analysis of small chemical molecules in a sample.
What are the advantages of using FPLC for protein purification in drug research and development?
FPLC offers high specificity and gentle purification conditions, preserving protein activity and structure, which is crucial for drug research. It is scalable, automated, and versatile and also allows for rapid, scalable purification, enabling efficient analysis and production of target proteins for drug development processes.
Can FPLC be used for environmental analysis, and how does it contribute to pollution monitoring?
Yes, FPLC can be used in environmental analysis to separate and quantify biomolecules such as enzymes or pollutants. It contributes to pollution monitoring by identifying contaminants, studying their effects on ecosystems, and aiding in bioremediation efforts.
How do you choose the right buffer for FPLC?
Choosing the right buffer for FPLC depends on factors such as the protein's pH stability, ionic strength requirements, and the type of chromatography being used. It is important to select a buffer that maintains the biomolecule’s structure and function, with appropriate salts and pH, to optimize interaction with the chromatography matrix. The selected buffers should not interfere with the activity of the target protein.
The concentration and the pH of the buffer used should be in line with the target protein. The salt requirements may vary as per the chromatographic approach, column, and elution gradients. For example, protein L affinity columns are more impacted by salt levels compared to protein A resins. The elution is facilitated at a high pH when the salt concentration is lowered in the mobile phase in protein L columns. The purification of targets (such as antibodies) can become more stringent when increasing the pH by reducing salt concentrations to remove weakly bound molecules.